Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

NCT01013103 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
HMG-CoA Reductase Inhibitor Toxicity
Atherosclerosis
Oxidative Stress
Endothelial Dysfunction

Interventions

DRUG: Atorvastatin, high vs low dose
DRUG: Atorvastatin vs Placebo

Sponsor

Hippocration General Hospital